STOCK TITAN

[144] Tectonic Therapeutic, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

PETER MCNAMARA reported insider sales of Common stock under 10b5-1 plans. The filing lists two 10b5-1 sale transactions: 1,650 shares on 03/04/2026 for $41,250.00 and 1,649 shares on 03/03/2026 for $36,376.94. The form also notes prior option exercises (3,547 and 2,715 shares with exercise dates shown).

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Tectonic Therapeutic Inc

NASDAQ:TECX

View TECX Stock Overview

TECX Rankings

TECX Latest News

TECX Latest SEC Filings

TECX Stock Data

638.41M
10.67M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
WATERTOWN